Navigation Links
Isolation and Characterization of Anti-Viral Nucleoside Compounds from the Chinese Herb Taraxacum Mongolicum

Characterization of nucleotide and nucleoside analogs from Taraxacum mongolicum, a Chinese medicinal herb was achieved for the first time using liquid chromatography tandem mass spectrometry (LC/MS/MS). The active ingredients in the herb were characterized using nucleotide and nucleoside standards with product and precursor scans of tandem mass spectrometry. The nucleoside analogs were believed to be major active ingredients which have anti-Herpes simplex virus type 1 properties. While other methods are needed for the positive compound identification, the LC/MS/MS does provide a valuable tool for the characterization of active ingredients in natural products.


Many emerging viruses pose threats to our world as we enter the twenty-first century. The association of viruses with many life-threatening diseases makes it necessary to examine variform treatments for viral infections. Herbal medicines are currently being sought after for viral diseases because customary treatments are not proving very effective. We have shown that the aqueous and methanolic herbal extracts of the Chinese herb Taraxacum mongolicum have anti-Herpes simplex virus type-1 properties in vitro. Using liquid chromatography tandem mass spectrometry (LC/MS/MS) approaches and other spectroscopic and chromatographic techniques, we have tentatively identified the active ingredients as nucleoside analogs. Currently there are only a few classes of drugs with anti-HSV-1 properties, including nucleotide and nucleoside analogs. LC/MS/MS conditions were optimized using several nucleotide and nucleoside drug standards that are commercially available. Precursor and product ion scan modes were used to screen nucleotide and nucleoside analogs in the herbal extract. Three nucleoside analogs were found in Taraxacum mongolicum and their chemical structures were proposed.

Method/experimental conditions

Sample Preparation

10 g dried Taraxacum mongolicum boiled in 100 mL methanol for 45 minutes

Liquid subsequently filtered with Whatman grade filter paper

Methanol roto-evaporated, leaving residue

Residue reconstituted in mobile phase to place on LC/MS LC Conditions Column: YMC C18, 2.1x250 mm, 5 μm

Flow rate: 300 μl/min

Mobile phase: A-acetonitrile, B-2 mM ammonium acetate

Gradient: 5-60% ACN in 10 min and hold for 2 min

Injection: 10 μl

Autosampler: PE series 200 MS Conditions

API 2000TM LC/MS/MS System triple quadruple mass spectrometer

Ion source: TurboIonSpray source, positive & negative modes

Scan modes: Product and precursor scans

Study Design

There are three major chemical analogs that have anti-viral activities: protease inhibitors, nucleotide, and nucleoside analogs. Protease inhibitors are synthetic compounds while nucleotide and nucleoside analogs are found in natural products. To screen nucleotides: Four nucleotide standards in adequate solutions were infused into MS/MS for optimization of the instrument. The commonproduct ions of 159 and 79 m/z were used for the precursor scans of potential nucleotide analogs in the crude extract samples under the same LC/MS/MS conditions for nucleotide standards. To screen nucleosides: Three nucleoside standards were tested under optimized MS/MS conditions. The most abundant product ion was the base fragment for all three nucleoside standards. Known nucleoside structures were searched and all base fragments were calculated. These base fragments were used for precursor ion scans of potential nucleoside analogs in the crude extract under optimized LC/MS/MS conditions for nucleoside standards.


This method shows a successful example of using the LC/MS/MS methodology for identifying the presence of nucleotide and nucleoside analogs in crude herbal extract samples. This technology can be used as a general tool to characterize other natural products.

The extraction method was simple and effective. Following a rational study design, the powerful LC/MS/MS method allows a direct injection of a crude herbal extract to characterize active ingredients such as nucleoside and nucleotide analogs in herbs.

The results demonstrated that there may be at least three nucleoside analogs present in the herbal extract of Taraxacum mongolicum. Since this herb has anti-Herpes simplex virus type-1 properties, the nucleoside analogs may be responsible for the anti-viral activities. To positively identify the chemical structures, more experiments are being conducted, such as NMR and Qq-TOF for detailed structure elucidation and exact molecular weight measurement. The identified peaks will also be tested for antiviral activities in vitro.



Page: All 1 2 3

Related biology technology :

1. Fast and Easy Isolation of PCR-Ready Genomic DNA from Whole Blood
2. High-Throughput Isolation of Total RNA
3. Simple Isolation of RNA from Tissue and Cultured Cells
4. Fast Isolation of Total RNA from Small Numbers of Cells
5. Comparison of Growth Techniques and Media for the Purpose of Plasmid Isolation from E. coli Using the Eppendorf Perfectprep Plasmid Mini Kit
6. Isolation of Microorganisms
7. Isolation of Genomic DNA from Saliva Using the Perfect gDNA Blood Mini Kit
8. Mouse Tail Genomic DNA Isolation Protocol(1)
9. Genomic DNA Isolation Protocol(1,2,3)
10. Basic Plasmid DNA Isolation Protocol
11. Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock Gel-Heavy
Post Your Comments:

(Date:11/30/2015)... 30, 2015  Northwest Biotherapeutics (NASDAQ: NWBO ) ... immune therapies for solid tumor cancers, announced today that ... director, and the Company welcomes Neil Woodford,s ... recent anonymous internet report on NW Bio.  The Company,s ... Linda Powers stated, "We agree with Mr. Woodford ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... Program that includes over 2,000 technical presentations offered in symposia, oral sessions, ... and applied spectroscopy, covers a wide range of applications such as, but not ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: ... adopted a stockholder rights plan (Rights Plan) in an ... loss carryforwards (NOLs) under Section 382 of the Internal ... --> PharmAthene,s use of its NOLs could be ... as defined in Section 382 of the Code. In ...
(Date:11/25/2015)... QUEBEC CITY , Nov. 25, 2015 /PRNewswire/ ... "Company"), affirms that its business and prospects remain ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB ... program to completion following review of the final ... met Phase 2 Primary Endpoint in men with ...
Breaking Biology Technology:
(Date:11/9/2015)... , Nov. 09, 2015 ... addition of the "Global Law Enforcement ... offering. --> ) has ... Law Enforcement Biometrics Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
(Date:10/29/2015)... Va. , Oct. 29, 2015 Daon, ... today that it has released a new version of ... customers in North America have ... IdentityX v4.0 also includes a FIDO UAF certified ... are already preparing to activate FIDO features. These customers ...
Breaking Biology News(10 mins):